Search

everythinglearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The woman has Discoid Lupus Erythematosus and needs specialist care.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The document explains various skin conditions and their treatments.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.